SynthesisFrontiers in microbiology2025
Global research trends on the relationship between gut microbiota and melanoma from 2014 to 2023: a bibliometric and visualization analysis.
Synthesis in Frontiers in microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Melanoma, a type of malignant tumor, originates from skin cells known as melanocytes. The gut microbiota is closely linked to melanoma, and this bibliometric analysis aims to guide future studies and advance research into the role of the gut microbiome in melanoma. We used the Web of Science Core Collection database to identify relevant literature on the function of intestinal flora in melanoma from 2014-2023, and bibliometric analysis and network visualization were performed with VOSviewer, CiteSpace. A total of 886 articles were identified, with significant contributions from the United States, France, and China. The role of gut microbiota in the onset, progression, and treatment of melanoma is becoming increasingly clear, especially in its potential to improve immunotherapy outcomes. In conclusion, this research used bibliometric analysis to perform a thorough quantitative and qualitative evaluation of the literature concerning the role of gut microbiota in melanoma. Advancing research in this area offers hope for enhancing melanoma treatments by regulating the gut microbiome, which could lead to improved patient outcomes in the future.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.